Abstract

Accumulation of amyloid-beta (Aβ) into amyloid plaques and hyperphosphorylated tau into neurofibrillary tangles (NFTs) are pathological hallmarks of Alzheimer’s disease (AD). There is a significant intra- and inter-individual variability in the morphology and conformation of Aβ aggregates, which may account in part for the extensive clinical and pathophysiological heterogeneity observed in AD. In this study, we sought to identify an array of fluorescent dyes to specifically probe Aβ aggregates, in an effort to address their diversity. We screened a small library of fluorescent probes and identified three benzothiazole-coumarin derivatives that stained both vascular and parenchymal Aβ deposits in AD brain sections. The set of these three dyes allowed the visualization of Aβ deposits in three different colors (blue, green and far-red). Importantly, two of these dyes specifically stained Aβ deposits with no apparent staining of hyperphosphorylated tau or α-synuclein deposits. Furthermore, this set of dyes demonstrated differential interactions with distinct types of Aβ deposits present in the same subject. Aβ aggregate-specific dyes identified in this study have the potential to be further developed into Aβ imaging probes for the diagnosis of AD. In addition, the far-red dye we identified in this study may serve as an imaging probe for small animal imaging of Aβ pathology. Finally, these dyes in combination may help us advance our understanding of the relation between the various Aβ deposits and the clinical diversity observed in AD.

Highlights

  • Misfolding, aggregation and deposition of amyloid-beta (Aβ) peptide into amyloid plaques (APs) and tau protein into neurofibrillary tangles (NFTs) are pathological hallmarks of Alzheimer’s disease (AD) (Serrano-Pozo et al, 2011)

  • We identified two novel fluorescent probes, which detect Aβ deposits in AD brain with no recognition of phosphorylated (Ser202/Thr205) tau

  • TC was shown to stain Lewy bodies (LBs) in Lewy Body Disease (LBD) cases, while benzothiazole-coumarin derivative 6 (BC6) and benzothiazole-coumarin derivative 15 (BC15) did not show any staining in LBD sections

Read more

Summary

Introduction

Misfolding, aggregation and deposition of amyloid-beta (Aβ) peptide into amyloid plaques (APs) and tau protein into neurofibrillary tangles (NFTs) are pathological hallmarks of Alzheimer’s disease (AD) (Serrano-Pozo et al, 2011). Most commonly used fluorescent probes for neuropathological analysis of Aβ aggregates, such as Thioflavin-S (ThS), and Congo Red, recognize common β-sheet structures, which can be shared by all amyloids, including tau and α-synuclein (α-syn) aggregates (Vassar and Culling, 1959; Kelényi, 1967a,b; Naiki et al, 1989; Levine, 1993; Robbins et al, 2012). They suffer from poor selectivity, which is a critical issue for reliable diagnosis. This necessitates the development of versatile and sensitive probes for the detection of a wide range of heterogeneous pathogenic Aβ conformational variants

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.